UPDATED Dec 03, 2025
Discover Indian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NIFTY and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
DCAL | ₹228.56 | -4.8% | -13.9% | ₹37.1b | n/a | PE26.3x | n/a | 0% | ||
540694 | ₹28.81 | 8.1% | -38.4% | ₹383.1m | n/a | PB0.6x | n/a | 0% | ||
530239 | ₹171.40 | -0.9% | 28.2% | ₹39.5b | n/a | PS665x | n/a | 0% | ||
NECLIFE | ₹20.94 | 47.9% | -38.2% | ₹4.0b | n/a | PB0.7x | n/a | 0% | ||
531398 | ₹138.65 | 3.1% | -42.2% | ₹858.7m | n/a | PE30x | n/a | 0% |